Document Detail


Effect of cardiotropic agents on the myocardial dysfunction of hyperdynamic sepsis.
MedLine Citation:
PMID:  4053297     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have previously shown that in vitro myocardial performance is impaired in rats during the hyperdynamic, hypermetabolic phase of sepsis. Although the heart in the resting animal generated an elevated cardiac output, the isolated, perfused heart showed a depressed ventricular function curve. In the present studies, interventions to improve contractile function (increased perfusate calcium concentration or perfusion with ouabain) or to decrease calcium availability to the myofibrils (verapamil and tetracaine) were investigated using the isolated perfused working heart. These studies showed that increasing or decreasing calcium concentration in the perfusion medium had little effect on ventricular performance in the septic group, whereas ouabain enhanced performance by approximately 25%. Addition of verapamil at a dose that caused a minimal decrease in myocardial work (cardiac output X peak systolic pressure) in control hearts showed a 20-25% increase in work in the experimental hearts. Increased levels of verapamil caused a greater depression in myocardial performance in the control hearts than in the hearts from septic rats. Thus, it appears that a multifaceted defect may be present in these hearts with a derangement that can be slightly improved with either ouabain or verapamil. Since neither intervention could completely reverse the myocardial dysfunction in hyperdynamic sepsis, it appears that the defect may be due to other factors in addition to calcium availability for contraction.
Authors:
K H McDonough; C H Lang; J J Spitzer
Related Documents :
21745227 - Assessment of atrial conduction time in patients with coronary artery ectasia.
16204707 - Association of ischemia on stress (99m)tc-tetrofosmin myocardial perfusion imaging with...
18682407 - Detection of myocardial ischaemia caused by coronary artery-left ventricular fistulae u...
6687947 - Release of purine nucleosides and oxypurines from the isolated perfused rat heart.
10772367 - Relationship between benign prostatic hyperplasia and history of coronary artery diseas...
21187997 - Protocol-guided phase-1 cardiac rehabilitation in patients with st-elevation myocardial...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulatory shock     Volume:  17     ISSN:  0092-6213     ISO Abbreviation:  Circ. Shock     Publication Date:  1985  
Date Detail:
Created Date:  1985-12-13     Completed Date:  1985-12-13     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0414112     Medline TA:  Circ Shock     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1-19     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Blood Pressure / drug effects
Calcium / metabolism,  pharmacology
Cardiac Output / drug effects
Cardiovascular Agents / pharmacology*
Heart / drug effects*,  physiopathology
Male
Myocardial Contraction / drug effects
Ouabain / pharmacology
Rats
Rats, Inbred Strains
Sepsis / drug therapy,  physiopathology*
Tetracaine / pharmacology
Verapamil / pharmacology
Grant Support
ID/Acronym/Agency:
GM 32371/GM/NIGMS NIH HHS; HL 07098/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Cardiovascular Agents; 52-53-9/Verapamil; 630-60-4/Ouabain; 7440-70-2/Calcium; 94-24-6/Tetracaine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Studies on the site of the block in gluconeogenesis causing severe hypoglycemia in intestinal ischem...
Next Document:  Effects of scald injury on hepatic PO2, blood flow, and ultrastructure in the rat.